OpenURL Connection Search

Select item for more details and to access through your institution.

CYP46A1 gene therapy deciphers the role of brain cholesterol metabolism in Huntington's disease.
Published in:
2019
By:
- Kacher, Radhia;
- Lamazière, Antonin;
- Heck, Nicolas;
- Kappes, Vincent;
- Mounier, Coline;
- Despres, Gaëtan;
- Dembitskaya, Yulia;
- Perrin, Elodie;
- Christaller, Wilhelm;
- Nair, Satish Sasidharan;
- Messent, Valérie;
- Cartier, Nathalie;
- Vanhoutte, Peter;
- Venance, Laurent;
- Saudou, Frédéric;
- Néri, Christian;
- Caboche, Jocelyne;
- Betuing, Sandrine;
- Sasidharan Nair, Satish
Publication type:
journal article
CYP46A1, the rate-limiting enzyme for cholesterol degradation, is neuroprotective in Huntington's disease.
Published in:
2016
By:
- Boussicault, Lydie;
- Alves, Sandro;
- Lamazière, Antonin;
- Planques, Anabelle;
- Heck, Nicolas;
- Moumnè, Lara;
- Despres, Gaëtan;
- Bolte, Susanne;
- Hu, Amèlie;
- Pagès, Christiane;
- Galvan, Laurie;
- Piguet, Francoise;
- Aubourg, Patrick;
- Cartier, Nathalie;
- Caboche, Jocelyne;
- Betuing, Sandrine;
- Moumné, Lara;
- Hu, Amélie
Publication type:
journal article
Dendrogenin A Synergizes with Cytarabine to Kill Acute Myeloid Leukemia Cells In Vitro and In Vivo.
Published in:
Cancers, 2020, v. 12, n. 7, p. 1725, doi. 10.3390/cancers12071725
By:
- Serhan, Nizar;
- Mouchel, Pierre-Luc;
- de Medina, Philippe;
- Segala, Gregory;
- Mougel, Aurélie;
- Saland, Estelle;
- Rives, Arnaud;
- Lamaziere, Antonin;
- Despres, Gaëtan;
- Sarry, Jean-Emmanuel;
- Larrue, Clément;
- Vergez, François;
- Largeaud, Laetitia;
- Record, Michel;
- Récher, Christian;
- Silvente-Poirot, Sandrine;
- Poirot, Marc
Publication type:
Article
Modulation of Brain Cholesterol Metabolism through CYP46A1 Overexpression for Rett Syndrome.
Published in:
Pharmaceutics, 2024, v. 16, n. 6, p. 756, doi. 10.3390/pharmaceutics16060756
By:
- Audouard, Emilie;
- Khefif, Nicolas;
- Gillet-Legrand, Béatrix;
- Nobilleau, Fanny;
- Bouazizi, Ouafa;
- Stanga, Serena;
- Despres, Gaëtan;
- Alves, Sandro;
- Lamazière, Antonin;
- Cartier, Nathalie;
- Piguet, Françoise
Publication type:
Article

Found: 4

CYP46A1 gene therapy deciphers the role of brain cholesterol metabolism in Huntington's disease.

CYP46A1, the rate-limiting enzyme for cholesterol degradation, is neuroprotective in Huntington's disease.

Dendrogenin A Synergizes with Cytarabine to Kill Acute Myeloid Leukemia Cells In Vitro and In Vivo.

Modulation of Brain Cholesterol Metabolism through CYP46A1 Overexpression for Rett Syndrome.